The Relationship of Vitamin D Topolycystic Ovary Syndrome (PCOS) Teenagers at Koto Tangah Padang District High School in 2022
DOI:
https://doi.org/10.25077/aoj.8.1.615-631.2024Keywords:
Adolescent, PCOS, Vitamin DAbstract
PCOS is characterized by increased ovarian and adrenal androgen secretion, hyperandrogenic symptoms such as hirsutism, acne and/or alopecia, menstrual irregularities, and polycystic ovaries. The prevalence of PCOS in 2016 was 6−21% of reproductive age worldwide. PCOS is the most common female endocrine disorder with a prevalence of around 4-6% in women of reproductive age in Indonesia. Vitamin D deficiency can increase PCOS symptoms. The research design was cross-sectional. The study was conducted at SMA N 7, SMA N 8 and SMA N 13 Padang in Koto Tangah District in May-August 2022. The research sample was high school students who experienced menstrual cycle disorders and were willing to agree to informed consent for the study with a sample size of 59 respondents. Vitamin D levels were examined using the 25-Hydroxyvitamin D ELISA Kit. Data were analyzed by chi-square test. The results showed that 86.4% of respondents experienced vitamin D deficiency. Statistically there was a relationship between PCOS in adolescents accompanied by hyperandrogens and vitamin D levels, there was a relationship between PCOS in adolescents accompanied by obesity and vitamin D levels, there was no relationship between PCOS in adolescents accompanied by acanthosis nigrican and vitamin D levels, and there was no relationship between PCOS in adolescents accompanied by hyperandrogens, obesity and acanthosis nigrican with vitamin D levels in SMA Koto Tangah District Padang in 2022. The conclusion of this study is that there is a relationship between PCOS in adolescents accompanied by hyperandrogens and vitamin D levels and there is a relationship between PCOS in adolescents accompanied by obesity and vitamin D levels.
References
Pena AS, Witchel SF, Hoeger KM, Oberfield SE, Vogiatzi MG, Misso M, et al. Adolescent polycystic
ovary syndrome according to the international evidence-based guideline. BMC Med. 2020;18(1):72.
Schorge JO, Williams JW. Menopausal Transition: McGraw-Hill Medical; 2008.
Wehr E, Trummer O, Giuliani A, Gruber HJ, Pieber TR, Pietsch BO. Vitamin D-associated
polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
Eur J Endocrinol. 2011;164(5):741-9.
Aziza DO, Kurniati KI. Vitamin D supplementation in women with Polycystic Ovarian Syndrome (PCOS).
Sandi Husada Health Scientific Journal. 2019;8(2):169-77.
Trummer C, Pilz S, Schwetz V, Pietsch BO, Lerchbaum E. Vitamin D, PCOS, and androgens in men: a
systematic review Endocr Connect. 2018;7(3):R95-R113.
Santoso B. Polycystic Ovary Syndrome: Reproductive Problems and Challenges Related to the
Lifestyle of Indonesian Women Surabaya: Faculty of Medicine, Airlangga University; 2014.
Desmawati, Febri RR, Hestiantoro A, Asmarinah. DNA methylation of the androgen receptor gene
promoter in the granulosa cells of polycystic ovary syndrome patients. J Phys: Conf Ser. 2018;1073(3).
Setiawati I, Purwanto B, Miftahussurur M, Joewono HT, Budiono, Santoso B. Effects of Moringa oleifera
Leaf Extract to Risk of Endometrial Hyperplasia in Polycystic Ovary Syndrome Model with Insulin
Resistance. J Int Dent Med Res. 2018;11(3):1123-9.
Agency for Health Research and Development. Basic Health Research 2010. Jakarta: Indonesian
Ministry of Health; 2010.
Oliveira A, Sampaio B, Teixeira A, Correia CC, Fontoura M, Medina JL. Polycystic ovary syndrome:
Challenges in adolescence. Endocrinol Nutr. 2010;57(7):328-36.
HIFERI, POGI. Consensus on the Management of Polycystic Ovary Syndrome. Jakarta: HIFERI; 2016.
Dadachanji R, Shaikh N, Mukherjee S. Genetic Variants Associated with Hyperandrogenemia in PCOS
Pathophysiology. Genetics Research International. 2018;2018:1-12.
Branavan U, Muneeswaran K, Wijesundera S, Jayakody S, Chandrasekharan V, Wijeyaratne C.
Identification of selected genetic polymorphisms in polycystic ovary syndrome in Sri Lankan women
using low cost genotyping techniques. Plos One. 2018;13(12):1-19.
Kamboj MK, Bonny AE. Polycystic ovary syndrome in adolescence: diagnostic and therapeutic
strategies. Transl Pediatr. 2017;6(4):248-55.
Thomas SI, Gawde U, Bhaye S, Pokar K, Bader GD. Meta-analysis of gene expression profiles of lean
and obese PCOS to identify differentially regulated pathways and risk of comorbidities. Computational
and Structural Biotechnology Journal. 2020;18(2020):1735-45.
Walters KA. Polycystic ovary syndrome: Is it androgen or estrogen receptor? Current opinion in
Endocrine and Metabolic Research. 2020;12:1-7.
Herlambang, Safira NNA, Fitri AD, Puspasari A. Description of Vitamin D Levels in Women of
Childbearing Age in Jambi City: Initial Efforts to Develop a Reproductive Health Policy Model. Medic
Medical Dedication. 2021;4(2):269-73.
Islamy A, Farida. Factors that Influence the Menstrual Cycle in Level III Adolescent Girls. Journal of
Psychiatric Nursing. 2019;7(1):13-8.
Shita NKDSS, Purnawati S. Prevalence of Menstrual Disorders and Influencing Factors among Female
Students Taking National Examinations at SMA Negeri 1 Melaya, Jembrana Regency. Medical E-
Journal. 2016;5(3):1-9.
Roe AH, Dokras A. The diagnosis of Polycystic Ovary Syndrome in Adolescents. Rev Obstet Gynecol.
;4(2):45-51.
Witchel SF, Oberfield SE, Peña AS. Polycystic Ovary Syndrome: Pathophysiology, Presentation, and
Treatment With Emphasis on Adolescent Girls. Journal of the Endocrine Society. 2019;3(8):1545-73.
BPS. Number of School Age Population According to Gender in 2017 2018 [Available
from:https://sumbar.bps.go.id/statictable/2018/04/17/423/jumlah-penduduk-umur-sekolah-sumatera-
barat-menurut-jenis-kelamin-dan-kabupaten-kota-tahun-2017.html.
Ministry of Education and Culture. NUMBER OF EDUCATIONAL UNIT (SCHOOL) DATA PER
DISTRICT/CITY: Padang City 2021 [Available
from:https://referensi.data.kemdikbud.go.id/index11.php?kode=086100&level=2.
Mogili KD, Karuppusami R, Thomas S, Chandy A, Kamath MS, Tk A. Prevalence of vitamin D deficiency
in infertile women with polycystic ovarian syndrome and its association with metabolic syndrome – A
prospective observational study. Eur J Obstet Gynecol Reprod Biol 2018;229:15-9.
Hoffman BL, Schorge JO, Halvorson LM, Hamid CA, Corton MM, Schaffer JI. Williams Gynecology
Fourth Edition. United States: Mc Graw Hill; 2020.
Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The
Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocrine Reviews.
;37(5):467-520.
Owens LA, Kristensen SG, Lerner A, Christopoulos G, Lavery S, Hanyaloglu AC, et al. Gene Expression
in Granulosa Cells From Small Antral Follicles From Women With or Without Polycystic Ovaries. The
Journal of Clinical Endocrinology & Metabolism. 2019;104(12):6182-92.
Ahmadi S, Jamilian M, Karamali M, Ebrahimi MT, Jafari P, Taghizadeh M, et al. Probiotic
supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic
ovary syndrome: a randomized, double-blind, placebo-controlled trial. Human Fertility. 2017;20(4):254-
Edmonds DK, Dewhurst J. Dewhurst’s Textbook of Obstetrics & Gynaecology. London, UK: 7th ed.
Blackwell Pub; 2007.
McCartney CR, Marshall JC. Polycystic Ovary Syndrome. N Engl J Med. 2016;375(1):54-64.
Murase T, Iwase A, Komatsu K, Bayasula, Nakamura T, Osuka S, et al. Follicle dynamics: visualization
and analysis of follicle growth and maturation using murine ovarian tissue culture. J Assist Reprod
Genet. 2018;35(2):339-43.
Sutandar Y, Santoso SSI. The mechanism of human ovarian primordial follicular assembly and
development. Journal of Reproductive Health. 2015;2(1):40-6.
Jones ASK, Shikanov A. Follicle development as an orchestrated signaling network in a 3D organoid.
Journal of Biological Engineering. 2019;13(2):1-12.
Pepling M. Oocyte Development before and during Folliculogenesis. In Oocyte Physiology and
Development in Domestic Animals: Wiley Blackwell; 2013. p. 1-19.
Watson AJ. Oocyte cytoplasmic maturation: a key mediator of oocyte and embryo developmental
competence J Anim Sci. 2007;85:E1-E3.
Richards JS, Pangas SA. The ovary: basic biology and clinical implications. Journal of Clinical
Investigation. 2010;120(4):963-72.
Holesh JE, Bass AN, Lord M. Physiology, Ovulation: StatPearls Publishing; 2022.
Hoshino Y. Updating the markers for oocyte quality evaluation: intracellular temperature as a new index.
Reprod Med Biol. 2018;17(4):434-41.
Miao YL, Kikuchi K, Sun QY, Schatten H. Oocyte aging: cellular and molecular changes, developmental
potential and reversal possibility. Human Reproduction Update. 2009;15(5):573-85.
Prasad S, Tiwari M, Pandey AN, Shrivastav TG, Chaube SK. Impact of stress on oocyte quality and
reproductive outcome. Journal of Biomedical Science. 2016;23(1):36.
Moghadam ARE, Moghadam MT, Hemadi M, Saki G. Oocyte quality and aging. JBRA Assist Reprod.
;26(1):105-22.
Miao Y, Ma S, Liu X, Miao D, Chang Z, Luo M, et al. Fate of the first polar bodies in mouse oocytes.
Mol Reprod Dev. 2004;69(1):66-76.
Stojkovic M, Machado SA, Stojkovic P, Zakhartchenko V, Hutzler P, PB Ga. Mitochondrial Distribution
and Adenosine Triphosphate Content of Bovine Oocytes Before and After In Vitro Maturation:
Correlation with Morphological Criteria and Developmental Capacity After In Vitro Fertilization and
Culture1. Biology of Reproduction. 2001;64(3):904-9.
Lessey BA, Young SL. What exactly is endometrial receptivity? Fertility and Sterility. 2019;111(4):611-
Malhotra N, Malhotra J, Singh A, Gupta P, Malhotra N. Endometrial receptivity and scoring for prediction
of implantation and newer markers. JSAFOG. 2017;9(2):143-54.
López-Luna A, Hernández-Melchor D, RamÃrez-MartÃnez L, López- Bayghen E. The Genetic and
Biochemical Blueprint of Endometrial Receptivity: Past, Present, and Future Factors Involved in Embryo
Implantation Success. In: Gomy I, editor. Modern Medical Genetics and Genomics: IntechOpen; 2018.
Monsivais D, Nagashima T, Prunskaite-Hyyryläinen R, Nozawa K, Shimada K, Tang S. Endometrial
receptivity and implantation require uterine BMP signaling through an ACVR2A-SMAD1/SMAD5 axis.
Nat Commun. 2021;12(1).
Vujovic S, Ivovic M, Tancic GM, Marina L, Arizanovic Z, Djogo A, et al. Detection and treatment of some
endometrial receptivity disorders-a way to improve fertility rates. Gynecological and Reproductive
Endocrinology and Metabolism. 2021;2(3):140-7.
Altmae S, Aghajanova L. Growth hormone and endometrial receptivity. Front Endocrinol. 2019;10(653).
Klonos E, Katopodis P, Karteris E, Papanikolaou E, Tarlatzis B, Pados G. Endometrial changes in
estrogen and progesterone receptor expression during implantation in an oocyte donation program.
Experimental and Therapeutic Medicine. 2020;20(6).
Liang YX, Liu L, Jin ZY, Liang XH, Fu YS, Gu XW. The high concentration of progesterone is harmful
for endometrial receptivity and decidualization. Scientific Reports. 2018;8(1).
Bai X, Zheng L, Li D, Xu Y. Research progress of endometrial receptivity in patients with polycystic
ovary syndrome: a systematic review. Reproductive Biology and Endocrinology. 2021;19(122).
Elnashar AM, Aboul-Enein GI. Endometrial receptivity. Middle East Fertility Society Journal. 2004;9(1).
Rafiee B, Bahmanpour S. Endometrial Receptivity In Art Cycles: A Review On Different Aspects Of
Improvement. Systematic Reviews in Pharmacy. 2021;12(3):54-67.
Eftekhar M, Mehrjardi SZ, Molaei B, Taheri F, Mangoli E. The correlation between endometrial thickness
and pregnancy outcomes in fresh ART cycles with different age groups: a retrospective study. Middle
East Fertility Society Journal. 2019;24(1).
Wang HUI, Shi G, Li M, Fan H, Ma H, Sheng LI. Correlation of il-1 and hb- egf with endometrial
receptivity. Experimental and Therapeutic Medicine. 2018;16(6):5130-6.
Cunningham, Leveno, Bloom, Hauth, Rouse, Spong. Williams Obstetrics. Jakarta: EGC; 2014.
Alsadi B. Polycystic Ovary Syndrome, Pathophysiology, and Reproductive Health Implications. 2018.
In: Pathophysiology - Altered Physiological States [Internet]. University of Westminster.
Mohammad MB, Seghinsara AM. Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH.
APJCP. 2017;18(1):17-21.
Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian syndrome (PCOS): Long-term metabolic
consequences. Metabolism. 2018;86:33-43.
Dunaif A, Chang RJ, Franks S. Polycystic Ovary Syndrome: Current Controversies, from the Ovary to
the Pancreas (Contemporary Endocrinology) 2008th edition. USA: Humana Press; 2008.
Paris VR, Bertoldo MJ. The Mechanism of Androgen Actions in PCOS Etiology. Med Sci (Basel).
;7(9):89.
Balen AH. Polycystic ovary syndrome (PCOS). Obstet Gynecol. 2017;19(2):119-29.
Hoeger KM, Oberfield SE. Do women with PCOS have a unique predisposition to obesity? Fertility and
Sterility. 2012;97(1):13-7.
Lucidi RS. Polycystic Ovarian Syndrome Treatment & Management 2019 [Available from:
https://emedicine.medscape.com/article/256806-treatment.
Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and
phenotypes of polycystic ovary syndrome. Fertility and Sterility. 2016;106(1):6-15.
Christakou C, Diamanti-Kandarakis E. Polycystic ovary syndrome – Phenotypes and diagnosis.
Scandinavian Journal of Clinical and Laboratory Investigation. 2014;74(sup244):18-22.
Azziz R, Kintziger K, Li R. Recommendations for epidemiologic and phenotypic research in polycystic
ovary syndrome: an androgen excess and PCOS society resource. Human Reproduction.
;34(11):2254-65.
Lanzo E, Monge M, Trent M. Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent
Girls. Pediatr Ann. 2015;44(9):e223-e30.
Poel YK, Koenders PP, Steegers-Theunissen RP, Boekel ET, Wee MM, Louwers Y, et al. Vitamin D
and metabolic disturbances in polycystic ovary syndrome (PCOS): A crosssectional study. Plos One.
;13(12):1-13.
Lua A, How C, King T. Managing polycystic ovary syndrome in primary care. Singapore Med J.
;59(11):567-71.
Boyle J, Teede HJ. Polycystic ovary syndrome - an update. Aust Fam Physician. 2012;41(10):752-6.
Kabel AM. Polycystic ovarian syndrome: insights into pathogenesis, diagnosis, prognosis,
pharmacological and non-pharmacological treatment. Pharm Bioprocess. 2016;4(1):7-12.
Silva MC, Furlanetto TW. Intestinal absorption of vitamin D: A systematic review. Nutrition Reviews.
;76(1):60-76.
Saraff V, Shaw N. Sunshine and vitamin D. Arch Dis Child. 2015;101(2):190-2.
Pilz S, Zittermann A, Trummer C, Theiler-Schwetz V, Lerchbaum E, Keppel MH, et al. Vitamin D testing
and treatment: A narrative review of current evidence. Endocrine Connections. 2019;8(2):R27-43.
Nair R, Maseeh A. Vitamin D: The sunshine vitamin. J Pharmacol Pharmacother. 2012;3(2):118-26.
Chang SW, Lee HC. Vitamin D and health - The missing vitamin in humans. Pediatr Neonatol.
;60(3):237-44.
Grzechocinska B, Dabrowski FA, Cyganek A, Wielgos M. The role of vitamin D in impaired fertility
treatment. Neuro Endocrinol Lett. 2013;34(8):756-62.
Eftekhar M, Mirhashemi ES, Molaei B, Pourmasumi S. Is there any association between vitamin D
levels and polycystic ovary syndrome (PCOS) phenotypes? Arch Endocrinol Metab. 2020;64(1):11-6.
Pfotenhauer KM, Shubrook JH. Vitamin D deficiency, its role in health and disease, and current
supplementation recommendations. J Am Osteopath Assoc. 2017;117(5):301-5.
Cermisoni GC, Alteri A, Corti L, Rabellotti E, Papaleo E, Viganò P, et al. Vitamin D and the endometrium:
A systematic review of a neglected area of research. Int J Mol Sci. 2018;19(8):2320.
Guo J, Liu S, Wang P, Ren H, Li Y. Characterization of VDR and CYP27B1 expression in the
endometrium during the menstrual cycle before embryo transfer: Implications for endometrial
receptivity. Reprod Biol Endocrinol. 2020;18(24).
Viganò P, Lattuada D, Mangioni S, Ermellino L, Vignali M, Caporizzo E, et al. Cycling and early
pregnancy endometrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol.
;36(3):415-24.
Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Köstenberger M, Tmava Berisha A,
et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Your J Clin Nutr.
;74(11):1498-513.
Grzesiak M, Waszkiewicz E, Wojtas M, Kowalik K, Franczak A. Expression of vitamin D receptor in the
porcine uterus and effect of 1,25(OH)2D3 on progesterone and estradiol-17β secretion by uterine
tissues in vitro. Theriogenology. 2019;125:102-8.
Hosseinirad H, Novin MG, Hosseini S, Nazarian H, Amidi F, Paktinat S. Effect of 1,25(OH)2-vitamin D3
on expression and phosphorylation of progesterone receptor in cultured endometrial stromal cells of
patients with repeated implantation failure. Acta Histochemica. 2020;122(2).
Kim CH. A functional relay from progesterone to vitamin D in the immune system. DNA and Cell Biology.
;34(6):379-82.
Carlberg C. Genome-wide (over) view on the actions of Vitamin D. Front Physiol. 2014;5(167).
Ganguly A, Tamblyn JA, Finn-Sell S, Chan SY, Westwood M, Gupta J, et al. Vitamin D, the placenta
and early pregnancy: effects on trophoblast function. J Endocrinol. 2018;236(2):R93-R103.
Pagliardini L, Vigano' P, Molgora M, Persico P, Salonia A, Vailati S, et al. High Prevalence of Vitamin
D Deficiency in Infertile Women Referring for Assisted Reproduction. Nutrients. 2015;7(12):9972-84.
El-Bahya AAZ, Radwanb RA, Gadc MZ, Maksoudc SMA. A Closer Insight into The Role of Vitamin D
in Polycystic Ovary Syndrome (PCOS). Glob J Pharmaceu Sci 2018;6(4):1-9.
Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-81.
Heyden EL, Wimalawansa SJ. Vitamin D: Effects on human reproduction, pregnancy, and fetal well-
being. J Steroid Biochem Mol Biol. 2018;180:41-50.
Rahimi-Ardabili H, Gargari BP, Farzadi L. Effects of vitamin D on cardiovascular disease risk factors in
polycystic ovary syndrome women with vitamin D deficiency. J Endocrinol Invest. 2013;36(1):28-32.
Abbas MA, Taha MO, Disi AM, Shomaf M. Regression of endometrial implants treated with vitamin D3
in a rat model of endometriosis. Eur J Pharmacol. 2013;715(1):72-5.
Irani M, Seifer DB, Grazi RV, Irani S, Rosenwaks Z, Tal R. Vitamin D Decreases Serum VEGF
Correlating with Clinical Improvement in Vitamin D-Deficient Women with PCOS: A Randomized
Placebo-Controlled Trial. Nutrients. 2017;9(334):1-8.
Pal L, Zhang H, Williams J, Santoro NF, Diamond MP, Schlaff WD, et al. Vitamin D Status Relates to
Reproductive Outcome in Women with Polycystic Ovary Syndrome: Secondary Analysis of a
Multicenter Randomized Controlled Trial. J Clin Endocrinol Metab. 2016;101(8):3027-35.
Guo S, Tal R, Jiang H, Yuan T, Liu Y. Vitamin D Supplementation Ameliorates Metabolic Dysfunction
in Patients with PCOS: A Systematic Review of RCTs and Insight into the Underlying Mechanism.
International Journal of Endocrinology. 2020;2020:1-18.
He C, Lin Z, Robb SW, Ezeamama AE. Serum Vitamin D Levels and Polycystic Ovary syndrome: A
Systematic Review and Meta-Analysis. Nutrients. 2015;7(6):4555-77.
Lumme J, Sebert S, Pesonen P, Piltonen T, Jarvelin MR, Herzig KH, et al. Vitamin D Levels in Women
with Polycystic Ovary Syndrome: A Population-Based Study. Nutrients 2019;11(2831):1-14.
Butts SF, Seifer DB, Koelper N, Senapati S, Sammel MD, Hoofnagle AN, et al. Vitamin D Deficiency Is
Associated With Poor Ovarian Stimulation Outcome in PCOS but Not Unexplained Infertility. J Clin
Endocrinol Metab. 2019;104(2):369-78.
Nandi A, Sinha N, Ong E, Sonmez H, Poretsky L. Is there a role for vitamin D in human reproduction?
Horm Mol Biol Clin Invest. 2016;25(1):15-28.
Sur D, Chakravorty R. Genetic Polymorphism in the Vitamin D Receptor Gene and 25-Hydroxyvitamin
D Serum Levels in East Indian Women with Polycystic Ovary Syndrome. J Mol Biomark Diagn.
;6(247):1-5.
Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG. Role of vitamin D treatment in glucose metabolism
in polycystic ovary syndrome. Fertil Steril. 2009;92(3):1053-8.
Maktabi M, Chamani M, Asemi Z. The Effects of Vitamin D Supplementation on Metabolic Status of
Patients with Polycystic Ovary Syndrome: A Randomized, Double. Horm Metab Res. 2017;49(7):493-
Li HWR, Brereton RE, Anderson RA, Wallace AM, Ho CKM. Vitamin D deficiency is common and
associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism.
;60(10):1475-81.
Joham AE, Teede HJ, Cassar S, Stepto NK, Strauss BJ, Harrison CL, et al. Vitamin D in Polycystic
Ovary Syndrome: Relationship to Obesity and Insulin Resistance. Mol Nutr Food Res. 2016;60(1):110-
Lemeshow S, Hosmer DW, Klar J, Lwanga SK. Adequacy of Sample Size in Health Studies. England:
John Wiley & Sons Ltd; 1990.
Saputra AND. Polycystic Ovary Syndrome (PCOS) in Adolescents: RSUP Dr. Sardjito; 2019 [Available
from: https://sardjito.co.id/2019/09/30/polycystic-ovary-syndrome-pcos-pada-belas/.
Kamrul-Hasan A, Aalpona FTZ, Selim S. Clinical, Metabolic, and Hormonal Profiles of Bangladeshi
Adolescents with Polycystic Ovary Syndrome. touchREVIEWS in Endocrinology. 2021;17(1):54-8.
Anisya V, Rodiani, Graharti R. Policystic Ovary Syndrome: Risk of Infertility that can be Prevented
through Weight Loss in Medullary Obese Women. 2019;9(1):267-75.
Mareta R, Amran R, Larasati V. The Relationship between Polycystic Ovary Syndrome (PCOS) and
Infertility in the Private Practice of Obstetrics, Gynecology, Palembang, Sriwijaya Medical Magazine.
;2:85-91.
Trummer C, Schwetz V, Kollmann M, Wolfler M, Munzker J, Pieber TR, et al. Effects of vitamin D
supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial.
European Journal of Nutrition. 2019;58:2019-28.
Morgante G, Darino I, Spano A, Luisi S, Luddi A, Piomboni P, et al. PCOS Physiopathology and Vitamin
D Deficiency: Biological Insights and Perspectives for Treatment. J Clin Med. 2022;11(4509):1-14.
Gokosmanoglu F, Onmez A, Ergenc H. The relationship between Vitamin D deficiency and polycystic
ovary syndrome. African Health Sciences. 2020;20(4):1880-6.
Davis EM, Peck JD, Hansen KR, Neas BR, Craig LB. Associations between Vitamin D Levels and
Polycystic Ovary Syndrome Phenotypes. Minerva Endocrinol. 2019;44:176-84.
Mesinovic J, Teede HJ, Shorakae S, Lambert GW, Lambert EA, Naderpoor N, et al. The Relationship
between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome. Nutrients.
;12(1219):1-8.
Kılınç S, Atay E, Ceran Ö, Atay Z. Evaluation of Vitamin D Status and Its Correlation with Gonadal
Function in Children at Mini-Puberty. Clin Endocrinol. Rev. 2019;90:122–8
Kalyanaraman R, Pal L. A Narrative Review of Current Understanding of the Pathophysiology of
Polycystic Ovary Syndrome: Focus on Plausible Relevance of Vitamin D. Int J Mol Sci.
;22(4905):1-18.
Shan C, Zhu YC, Yu J, Zhang Y, Wang YY, Lu N, et al. Low Serum 25-Hydroxyvitamin D Levels are
Associated with Hyperandrogenemia in Polycystic Ovary Syndrome: A Cross-Sectional Study Frontiers
in Endocrinology. 2022;3:1-11.
Wang L, Wen X, Lv S, Tian S, Jiang Y, Yang X. Effects of vitamin D supplementation on metabolic
parameters of women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.
Gynecol Endocrinol. 2021;37(5):446-55.
Kumar A, Barki S, Raghav V, Chaturvedi A, Kumar KVSH. Correlation of Vitamin D with metabolic
parameters in polycystic ovarian syndrome Journal of Family Medicine and Primary Care.
;6(1):115-9.
Contreras-Bolivar V, Garcia-Fontana B, Garcia-Fontana C, Munoz-Torres M. Mechanisms involved in
the relationship between vitamin D and insulin resistance: impact on clinical practice. Nutrients.
;13(3491):1-25.
Aghadavod E, Mollaei H, Nouri M, Hamishehkar H. Evaluation of relationship between body mass index
with vitamin D receptor gene expression and vitamin D levels of follicular fluid in overweight patients
with polycystic ovary syndrome. International Journal of Fertility and Sterility. 2017;11(2):105-11.
Radu AM, Carsote M, Dumitrascu MC, Sandru F. Acanthosis Nigricans: Pointer of Endocrine Entities.
Diagnostics. 2022;12(2519):1-29.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Hardi Cahyo Utomo, Haviz Yuad, Ida Rahmah Burhan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
Authors who publish with this journal agree to the following terms:
- Authors retain the copyright of published articles and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
License:
Andalas Obstetrics and Gynecology Journal (AOJ) is published under the terms of the Creative Commons Attribution 4.0 International License. This license permits anyone to copy and redistribute this material in any form or format, compose, modify, and make derivatives of this material for any purpose, including commercial purposes, as long as they credit the author for the original work.
